IDH1 Peptide Vaccine for Recurrent Grade II Glioma

Clinical trial NCT02193347 · COMPLETED

Trial details

NCT number: NCT02193347
Sponsor: Katy Peters, MD, PhD
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Cancer Brain Neoplasm, Primary Brain Neoplasms, Recurrent Brain Tumor Cancer of the Brain

Start date: 2016-01-28
Primary completion: 2020-02-03
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.